IBDEI1XP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33971,1,4,0)
 ;;=4^I69.044
 ;;^UTILITY(U,$J,358.3,33971,2)
 ;;=^5007407
 ;;^UTILITY(U,$J,358.3,33972,0)
 ;;=I69.841^^183^2013^72
 ;;^UTILITY(U,$J,358.3,33972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33972,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff right dom side
 ;;^UTILITY(U,$J,358.3,33972,1,4,0)
 ;;=4^I69.841
 ;;^UTILITY(U,$J,358.3,33972,2)
 ;;=^5007532
 ;;^UTILITY(U,$J,358.3,33973,0)
 ;;=I69.842^^183^2013^73
 ;;^UTILITY(U,$J,358.3,33973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33973,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff left dom side
 ;;^UTILITY(U,$J,358.3,33973,1,4,0)
 ;;=4^I69.842
 ;;^UTILITY(U,$J,358.3,33973,2)
 ;;=^5133577
 ;;^UTILITY(U,$J,358.3,33974,0)
 ;;=I69.843^^183^2013^70
 ;;^UTILITY(U,$J,358.3,33974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33974,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff right nondom side
 ;;^UTILITY(U,$J,358.3,33974,1,4,0)
 ;;=4^I69.843
 ;;^UTILITY(U,$J,358.3,33974,2)
 ;;=^5007533
 ;;^UTILITY(U,$J,358.3,33975,0)
 ;;=I69.844^^183^2013^71
 ;;^UTILITY(U,$J,358.3,33975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33975,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff left nondom side
 ;;^UTILITY(U,$J,358.3,33975,1,4,0)
 ;;=4^I69.844
 ;;^UTILITY(U,$J,358.3,33975,2)
 ;;=^5133578
 ;;^UTILITY(U,$J,358.3,33976,0)
 ;;=I69.241^^183^2013^74
 ;;^UTILITY(U,$J,358.3,33976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33976,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
 ;;^UTILITY(U,$J,358.3,33976,1,4,0)
 ;;=4^I69.241
 ;;^UTILITY(U,$J,358.3,33976,2)
 ;;=^5007469
 ;;^UTILITY(U,$J,358.3,33977,0)
 ;;=I69.242^^183^2013^75
 ;;^UTILITY(U,$J,358.3,33977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33977,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
 ;;^UTILITY(U,$J,358.3,33977,1,4,0)
 ;;=4^I69.242
 ;;^UTILITY(U,$J,358.3,33977,2)
 ;;=^5133574
 ;;^UTILITY(U,$J,358.3,33978,0)
 ;;=I69.243^^183^2013^76
 ;;^UTILITY(U,$J,358.3,33978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33978,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
 ;;^UTILITY(U,$J,358.3,33978,1,4,0)
 ;;=4^I69.243
 ;;^UTILITY(U,$J,358.3,33978,2)
 ;;=^5007470
 ;;^UTILITY(U,$J,358.3,33979,0)
 ;;=I69.244^^183^2013^77
 ;;^UTILITY(U,$J,358.3,33979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33979,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
 ;;^UTILITY(U,$J,358.3,33979,1,4,0)
 ;;=4^I69.244
 ;;^UTILITY(U,$J,358.3,33979,2)
 ;;=^5007471
 ;;^UTILITY(U,$J,358.3,33980,0)
 ;;=G35.^^183^2013^78
 ;;^UTILITY(U,$J,358.3,33980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33980,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,33980,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,33980,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,33981,0)
 ;;=G20.^^183^2013^79
 ;;^UTILITY(U,$J,358.3,33981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33981,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,33981,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,33981,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,33982,0)
 ;;=G21.4^^183^2013^80
 ;;^UTILITY(U,$J,358.3,33982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33982,1,3,0)
 ;;=3^Vascular parkinsonism
 ;;^UTILITY(U,$J,358.3,33982,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,33982,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,33983,0)
 ;;=I69.051^^183^2013^48
 ;;^UTILITY(U,$J,358.3,33983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33983,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,33983,1,4,0)
 ;;=4^I69.051
 ;;
 ;;$END ROU IBDEI1XP
